Spontaneous Bacterial Peritonitis (SBP) Prophylaxis
Long-term norfloxacin 400 mg once daily is the first-choice prophylaxis for patients who have had an episode of SBP, with ciprofloxacin 500 mg daily being the primary alternative when norfloxacin is unavailable. 1
Indications for SBP Prophylaxis
Secondary Prophylaxis (Prior SBP)
- All patients who survive an episode of SBP should receive indefinite antibiotic prophylaxis until liver transplantation or resolution of ascites due to the high recurrence rate (70% at 1 year) 1
- Without prophylaxis, survival rates are poor (30-50% at 1 year, 25-30% at 2 years) 1
Primary Prophylaxis (No Prior SBP)
Primary prophylaxis should be initiated in patients with:
- Low ascitic fluid protein (<1.5 g/dL) AND advanced liver disease (Child-Pugh score ≥9 with serum bilirubin >3 mg/dL, impaired renal function, or serum sodium <130 mEq/L) 1
- Cirrhotic patients with acute gastrointestinal hemorrhage (short-term prophylaxis for 5-7 days) 2, 1
Recommended Prophylactic Regimens
First-Line Options
- Norfloxacin 400 mg once daily - Most extensively studied regimen, reduces SBP recurrence from 68% to 20% 1
Alternative Options
- Ciprofloxacin 500 mg once daily - Primary alternative when norfloxacin is unavailable 2, 1
- Trimethoprim-sulfamethoxazole 800/160 mg daily - Alternative with similar efficacy to norfloxacin but potentially more adverse events 1
- Rifaximin - Emerging evidence suggests possibly superior efficacy compared to norfloxacin (4% vs 14% 6-month recurrence rate) 2, 1
Special Considerations
Gastrointestinal Bleeding
- All cirrhotic patients with ascites and acute GI hemorrhage should receive short-term antibiotic prophylaxis (5-7 days) 2, 1
- This reduces infection rates, decreases rebleeding risk, and improves survival 1
- This is the most frequently overlooked indication for SBP prophylaxis 3
Monitoring During Prophylaxis
- Regular assessment of renal function every 1-3 months 1
- Periodic cultures to detect resistant organisms 1
- Monitor for adverse effects of antibiotics, including:
- Fluoroquinolones: musculoskeletal and nervous system side effects
- Trimethoprim-sulfamethoxazole: rash, hyperkalemia, bone marrow suppression 1
Antibiotic Resistance Concerns
- Quinolone prophylaxis is less effective in patients colonized with multidrug-resistant organisms (MDRO) 2
- Healthcare-associated and nosocomial SBP infections may require alternative antibiotic coverage 4
Liver Transplantation Evaluation
- All patients who survive an episode of SBP should be considered for liver transplantation evaluation, as SBP represents a significant decompensating event with poor long-term prognosis 1
Common Pitfalls in SBP Prophylaxis
- Underutilization of prophylaxis - studies show up to 62% of SBP cases could have been prevented with proper adherence to guidelines 3
- Failure to recognize gastrointestinal hemorrhage as an indication for prophylaxis (44% of preventable cases) 3
- Inadequate long-term outpatient prophylaxis after discharge - only one-third of SBP survivors receive appropriate prophylaxis 3
- Overlooking high bilirubin levels (≥2.5 mg/dL) as an indication for prophylaxis 3
By following these evidence-based recommendations for SBP prophylaxis, clinicians can significantly reduce morbidity and mortality in patients with cirrhosis and ascites.